| DEC-NET Serial number IT498 | | | | Published online | 07/10/2005 10.09.00 | | Last updated | 07/10/2005 10.23.58 | | | | Other protocol ID number | | | Current trial status | Complete(closed to recruitment of participants: follow-up complete) | Major Disease
(ICD9 class) | COMPLICATIONS OF TRANSPLANTED BONE MARROW | | Experimental drug |
TACROLIMUS
Treatment regimen (dosage and duration)
N/A |
| Gender | Both | | Age (range) | 0-18 years |
Eligibility criteria | | | | |
Trial design/methodology | | Phase | | | Kind of study | | | Design | Controlled
| | | | | | | | |
|
|
| Promoter | | IRCCS - Istituto Giannina Gaslini (Scientific organisation) |
| Participating countries | | ITALY | | BELGIUM | | CZECH REPUBLIC | | SPAIN | | GERMANY | | SLOVENIA | | SWEDEN | | NETHERLANDS | | NEW ZEALAND |
| Participating centres | | Istituto Giannina Gaslini (Genova) | | Clinica di Oncoematologia Pediatrica (Padova) | | Ospedale San Gerardo (Monza (Milano)) | | Università "La Sapienza" (Roma) |
|
